Shilin Zhao
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 6
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 6
- Cancer-related molecular mechanisms research 6
- Biological Psychiatry top 10%
- Immunology top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 11
-
- AI in cancer detection 9
-
- Radiomics and Machine Learning in Medical Imaging 8
-
- Spinal Dysraphism and Malformations 7
- Co-authors
- Fei YeDouglas B. JohnsonDaniel WangQuanhu ShengYu ShyrYan GuoJeffrey A. SosmanKeith T. Wilson
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Shilin Zhao
120 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 150
- Oncology 525
- Cancer Research 236
- Biological Psychiatry 35
- Immunology 295
- Molecular Biology 728
Countries citing papers authored by Shilin Zhao
This map shows the geographic impact of Shilin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilin Zhao more than expected).
Fields of papers citing papers by Shilin Zhao
This network shows the impact of papers produced by Shilin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilin Zhao. The network helps show where Shilin Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shilin Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 24 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 111 | |
| 10 | 2021 | 36 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 84 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 37 | |
| 15 | 2018 | 60 | |
| 16 | 2018 | 17 | |
| 17 | 2017 | 35 | |
| 18 | 2017 | 74 | |
| 19 | 2016 | 16 | |
| 20 | 2014 | 1 |
About Shilin Zhao
Shilin Zhao is a scholar working on Biological Psychiatry, Cancer Research and Urology, having authored 130 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), AI in cancer detection (9 papers), Radiomics and Machine Learning in Medical Imaging (8 papers), Spinal Dysraphism and Malformations (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer-related molecular mechanisms research (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Oncology (525 citations), Cancer Research (236 citations) and Biological Psychiatry (35 citations). Shilin Zhao has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Fei Ye, Douglas B. Johnson, Daniel Wang, Quanhu Sheng, Yu Shyr, Yan Guo, Jeffrey A. Sosman, Keith T. Wilson, Yuankai Huo and Lori A. Coburn. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.